This page is part of the Adverse Event Clinical Research R4 Backport (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Page standards status: Informative |
Generated Narrative: MedicationRequest
Resource MedicationRequest "medication-request-example-kadcyla"
status: active
intent: order
medication: KADCYLA (RxNorm#1371046)
subject: Patient/patient-example-kaitlyn-b " BOUNCE"
authoredOn: 2020-03-12
requester: Practitioner/practitioner-owen-oncologist " ONCOLOGIST"
dosageInstruction
text: Kadcyla IV at 3.6mg
timing: Starting 2020-04-01, Once
route: Intravenous route (qualifier value) (SNOMED CT#47625008)
doseAndRate
maxDosePerAdministration: 1